Comparison of Drug Switching and Discontinuation Rates in Patients with Nonvalvular Atrial Fibrillation Treated with Direct Oral Anticoagulants in the United States

导出原文传递

翻译打印收藏纠错

作者： Baker, Christine L. ^[1] ; Dhamane, Amol D. ^[2] ; Mardekian, Jack ^[3] ; Dina, Oluwaseyi ; Russ, Cristina ; Rosenblatt, Lisa ; Lingohr-Smith, Melissa ; Menges, Brandy ; Lin, Jay ; Nadkarni, Anagha

作者单位： Novosys Hlth, Green Brook, NJ USA ^[1] Pfizer Inc, New York, NY 10017 USA ^[2] Bristol Myers Squibb, Lawrenceville, NJ USA ^[3]

关键词 Apixaban Cardiology Dabigatran Direct oral anticoagulants Drug discontinuation Drug switching Nonvalvular atrial fibrillation Rivaroxaban

发布时间 2019-07-27

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览3

Advances in therapy.

2019年36卷1期

162-174页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Comparison of Drug Switching and Discontinuation Rates in Patients with Nonvalvular Atrial Fibrillation Treated with Direct Oral Anticoagulants in the United States

Advances in therapy.

相似文献

Advances in therapy.

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Comparison of Drug Switching and Discontinuation Rates in Patients with Nonvalvular Atrial Fibrillation Treated with Direct Oral Anticoagulants in the United States

Advances in therapy.

相似文献

Advances in therapy.

相关期刊

检索历史清除